-
CALL US NOW FOR A QUOTE
CALL US NOW FOR A QUOTE
Global Pharmacokinetic market, by type (small molecule and large molecules) forecast till 2025
Market Scenario
Pharmacokinetic is a study of how body react to the drug. It monitors the chemical metabolism and analyzes chemical properties of the drugs from the moment it administered up to the time it get eliminated from the body. Pharmacokinetics involves the study of absorption, distribution and elimination of drugs in the body. It is a vital part in the process of drug discoveries. Stricter government regulation in approval of drugs in market is increases demand of the pharmacokinetics market. Clinical trial process for drugs is divided into four phases consisting evaluation of drugs compatibility to human being which include pharmacokinetics in third phase. Growing prevalence of chronic and newer diseases led pharmaceutical players to developed new drugs which propel the growth of the market. Technological advancement to developed new drug molecule and rising expenditure on R&D are boosting the growth of the market. Advantages of pharmacokinetics such as prior detection of challenges and thereby help in assisting needed modification is supports the growth of the market. Increasing competition within pharmaceutical companies led to invest in development of new drugs that can give them competitive edge can boost the growth of the market. Higher investment in R&D of new drug and chances of drug research failure can restraint the growth of the pharmacokinetics markets.
Segmentation
The global pharmacokinetics market is segmented on the basis of types.
On the basis of type, the market is segmented into small molecules and large molecules.
Regional Analysis
Presence of big pharmaceuticals companies, increased investment in R&D and stricter government regulation pertaining drug development processes are driving the growth of the market in North America. Growing industrialisation, increasing number of pharmaceutical companies and rising R&D activity are contributing to the growth of the pharmacokinetics market.
Key Players
Major players profiled in this market are: Charles River Laboratories International, Inc., PAREXEL International Corporation, Eurofins Scientific, Inc., Frontage Labs, SGS SA, LGC Limited, Evotec AG;Certara, L.P., Pacific BioLabs, GVK Biosciences Private Limited, Shanghai Medicilon Inc., Pharmaceutical Product Development, LLC, and Creative Bioarray.
Segmentation
By Type:
• Small Molecules
• Large Molecules
By Region:
• North America
• Europe
• Asia-Pacific
• LAMEA
Research Scope The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 2.2. Secondary Sources
The study for Global Pharmacokinetics Market will provide market size, estimates and forecast based on the following years:
Historic data: 2016 Base Year Estimate: 2017 Forecast: 2018 to 2025
Our analyst implement several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings.
The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market.
1. Introduction
1.1. Market Definition
1.2. Market Scope
2. Research Methodology
2.1. Primary Research
2.3. Assumptions & Exclusions
3. Market Overview
3.1. Research Report Segmentation & Scope
3.2. Key Market Trend Analysis
3.2.1. Market Drivers
3.2.2. Market Restraint/Challenges
3.2.3. Market Opportunities
3.3. Porter’s Five Forces Analysis
3.4. Potential Venture Avenues
3.5. Market Share Analysis, 2016
3.6. Market Overview
4. Type Overview
4.1. Introduction
4.2. Market Size & Forecast, 2015 to 2025
4.2.1. Small Molecules
4.2.2. Large Molecules
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)
5. Regional Overview
5.1. Introduction
5.2. Market Size & Forecast, 2015 to 2025
5.2.1. North America
5.2.1.1. U.S.
5.2.1.2. Canada
5.2.1.3. Mexico
5.2.2. Europe
5.2.2.1. UK
5.2.2.2. Germany
5.2.2.3. France
5.2.2.4. Italy
5.2.2.5. Spain
5.2.2.6. Rest of Europe
5.2.3. Asia-Pacific
5.2.3.1. China
5.2.3.2. India
5.2.3.3. Japan
5.2.3.4. South Korea
5.2.3.5. Rest of Asia-Pacific
5.2.4. LAMEA
5.2.4.1. Brazil
5.2.4.2. UAE
5.2.4.3. South Africa
5.2.4.4. Rest of LAMEA
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)
6. Manufacturer/ Vendor Profile
6.1. The following attributes will be considered while profiling key manufacturers in this industry:
6.1.1. Company Overview
6.1.2. Financial Synopsis
6.1.3. Recent Developments
6.1.4. R&D Investments (if any)
6.1.5. Strategy Overview (Analyst Perspective)
6.1.6. Product Portfolio
6.2. Companies Profiled
6.2.1. Charles River Laboratories International, Inc.
6.2.2. PAREXEL International Corporation
6.2.3. Eurofins Scientific, Inc.
6.2.4. Frontage Labs, SGS SA
6.2.5. LGC Limited
6.2.6. Evotec AG;Certara, L.P.
6.2.7. Pacific BioLabs
6.2.8. GVK Biosciences Private Limited
6.2.9. Shanghai Medicilon Inc.
6.2.10. Pharmaceutical Product Development, LLC
6.2.11. Creative Bioarray
6.2.12. Franklin International
6.2.13. Illinois Tool Works Incorporation
(Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.)
Get 15 minutes of free Consultation When you request a Sample Report!
24/7 Research ReportGet your queries resolved from an industry expert. Request for a free product review before report purchase.
Phone:
+1 513 549 5911 (US)
+44 203 318 2846 (UK)
Email: [email protected]